Clinical Trial Update: SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation [NA]

View source ↗

Summary

Clinical trial update for the Edwards SAPIEN M3 System Early Feasibility Study in mitral regurgitation; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation
• Mitral Valve Disease

Drugs mentioned

• SAPIEN M3 System

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Regurgitation, Mitral Disease | NA | Status: ACTIVE_NOT_RECRUITING